Sky’s the limit on iPS cell licensure cost from Academia Japan

I’ve been researching the issue of how intellectual property (IP) and patents to induced pluripotent stem (iPS) cell will influence the field. It’s a complicated, worrisome picture in terms of getting this technology to patients to help them. I’m concerned there may be an all out patent war. Even for those who do not go …

Sky’s the limit on iPS cell licensure cost from Academia Japan Read More »